{"id":526372,"date":"2021-01-14T18:32:01","date_gmt":"2021-01-14T18:32:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=526372"},"modified":"2021-01-14T18:32:01","modified_gmt":"2021-01-14T18:32:01","slug":"sepsis-diagnostics-market-worth-700-million-by-2025-key-players-are-biomrieux-france-becton-dickinson-company-us","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/sepsis-diagnostics-market-worth-700-million-by-2025-key-players-are-biomrieux-france-becton-dickinson-company-us_526372.html","title":{"rendered":"Sepsis Diagnostics Market Worth $700 Million by 2025 | Key Players are bioM\u00e9rieux (France), Becton Dickinson Company (US)"},"content":{"rendered":"
\"Sepsis<\/a><\/p>\n
\n
Some of the players in the sepsis diagnostics market are bioM\u00e9rieux (France), Becton Dickinson Company (US), Danaher (US), Abbott Laboratories (US), Roche Diagnostics (Switzerland), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), EKF Diagnostics (UK), Immunexpress (Australia), Response Biomedical (Canada), Axis-Shield Diagnostics (UK), and CytoSorbents (US).<\/div>\n<\/div>\n<\/div>\n
Sepsis Diagnostics Market Size Estimation and Analysis of Wide Range of Growth Opportunities for Industry Players.<\/div>\n

According to the new market research report “Sepsis Diagnostics Market by Technology (Microbiology, PCR, Microarray, Immunoassay, Biomarkers), Product (Reagents, Assay, Instruments, Software), Method, Test Type (Lab, POC), Pathogen (Bacterial, Fungal), End User and Region – Global Forecast to 2025”<\/strong>, published by MarketsandMarkets™, the global Sepsis Diagnostics Market size is expected to reach USD 700 million<\/span> by 2025 from USD 429 million<\/span> in 2019, at a CAGR of 8.5%.<\/p>\n

Download PDF Brochure:
<\/strong>https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=92673155<\/a><\/p>\n

The demand for sepsis diagnostic products is expected to grow mainly due to factors such as the rising prevalence of sepsis across the globe. Factors such as the increasing geriatric population, a growing number of surgical procedures, a high incidence of hospital-acquired infections, and the commercialization and availability of a wide variety of approved sepsis diagnostic devices are expected to drive market growth. Moreover, these factors have prompted market players to improve and strengthen their current manufacturing and distribution capabilities—especially in emerging markets, which are expected to witness the highest growth.<\/p>\n

Based on technology, the biomarkers segment is expected to register the highest growth rate during the forecast period<\/p>\n

<\/strong>Based on technology, the global sepsis diagnostics market is segmented into microbiology, molecular diagnostics, immunoassay, flow cytometry, microfluidics, and biomarkers. The biomarkers segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment can be attributed to various advantages offered by this technique in the diagnosis of sepsis and the growing need for early disease diagnosis.<\/p>\n

Browse in-depth TOC on<\/em> “<\/strong>Sepsis Diagnostics Market<\/a>“<\/p>\n

160 – Tables
<\/strong>36 – Figures  
<\/strong>199 – Pages<\/p>\n

<\/strong>Based on the product, the blood culture media segment accounted for the largest share of the market in 2019<\/p>\n

<\/strong>Based on products, the global sepsis diagnostics market is segmented into blood culture media, assays & reagents, instruments, and software. In 2019, the blood culture media segment accounted for the largest share of the market owing to the increased used of blood culture media as it is the standard method for the diagnosis of sepsis across the globe.<\/p>\n

North America<\/span> accounted for the largest share of the sepsis diagnostics market<\/p>\n

<\/strong>Geographically, the sepsis diagnostic market is segmented into North America<\/span>, Europe<\/span>, Asia Pacific<\/span>, and the Rest of the World. North America<\/span> is estimated to account for the largest share of the market in 2019. This can be attributed to the growing prevalence of sepsis, increasing incidence of hospital-acquired infections, fast adoption of high-end sepsis diagnostics devices, and rising government support for sepsis-related research.<\/p>\n

Request Sample Pages:
https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=92673155<\/a> <\/p>\n

<\/strong>Some of the prominent players in the sepsis diagnostics markets market are bioMérieux (France<\/span>), Becton Dickinson Company (US), Danaher (US), Abbott Laboratories (US), and Roche Diagnostics (Switzerland<\/span>). Other players include T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), EKF Diagnostics (UK), Immunexpress (Australia<\/span>), Response Biomedical (Canada<\/span>), Axis-Shield Diagnostics (UK), and CytoSorbents (US), among others.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> MarketsandMarkets<\/a>
Contact Person:<\/strong> Mr. Aashish Mehra
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 18886006441
Address:<\/strong>630 Dundee Road Suite 430
City:<\/strong> Northbrook
State:<\/strong> IL 60062
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.marketsandmarkets.com\/Market-Reports\/sepsis-diagnostic-market-92673155.html<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Some of the players in the sepsis diagnostics market are bioM\u00e9rieux (France), Becton Dickinson Company (US), Danaher (US), Abbott Laboratories (US), Roche Diagnostics (Switzerland), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), EKF Diagnostics (UK), Immunexpress (Australia), … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,417,406,404],"tags":[],"class_list":["post-526372","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/526372","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=526372"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/526372\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=526372"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=526372"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=526372"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}